Company-wide revenue
Reported revenue in 2021 ¥166.2B Reported revenue in 2025 ¥290.77B
- growth amount
- +¥124.57B
- growth annualized
- +15.0%
- growth total
- +75.0%
Japanese company profile · 3034
Qol Holdings Co.,Ltd.
In its FY2025 public filing, Qol Holdings Co.,Ltd. reports Insurance pharmacy business, Business Process Outsourcing (BPO) Business, Pharmaceuticals. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: クオールホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Qol Holdings Co.,Ltd.'s largest reported business by revenue in FY2025 was Insurance pharmacy business.
The business with the highest reported segment profit in FY2025 was Insurance pharmacy business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Insurance pharmacy business | ¥177.59B ↗ | 61.1% | ¥9.73B ↗ |
| Pharmaceuticals | ¥99.01B ↗ | 34.1% | ¥6.96B ↗ |
| Business Process Outsourcing (BPO) Business | ¥15.74B ↗ | 5.4% | ¥1.9B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Insurance pharmacy business
- 保険薬局事業
- Business Process Outsourcing (BPO) Business
- ＢＰＯ事業
- Pharmaceuticals
- 製薬事業
- Healthcare-related Business
- 医療関連事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Insurance pharmacy business
- 保険薬局事業
- Business Process Outsourcing (BPO) Business
- ＢＰＯ事業
- Pharmaceuticals
- 製薬事業
- Healthcare-related Business
- 医療関連事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Insurance pharmacy business | ¥153.16B | ¥155.45B | ¥165.19B | ¥171.74B | ¥177.59B |
| Business Process Outsourcing (BPO) Business | — | — | — | ¥14.88B | ¥15.74B |
| Pharmaceuticals | — | — | — | ¥78.73B | ¥99.01B |
| Healthcare-related Business | ¥13.47B | ¥14.99B | ¥15.34B | — | — |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Insurance pharmacy business
Reported revenue in 2021 ¥153.16B Reported revenue in 2025 ¥177.59B
- growth amount
- +¥24.42B
- growth annualized
- +3.8%
- growth total
- +15.9%
View original filing
Pharmaceuticals
First reported in 2024
Latest reported revenue ¥99.01B
View original filing
Business Process Outsourcing (BPO) Business
First reported in 2024
Latest reported revenue ¥15.74B
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YJYW
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.